Oliver Wyman Health

Roughly 60% of Americans under the age of 65, representing more than 160 million people, receive health coverage through an employer-sponsored health plan. Despite these numbers and a strong labor market, the employer-sponsored segment is not keeping pace with Medicare Advantage or the ACA. Employers are feeling the financial impact, as per-employee healthcare costs are projected to rise 5.4% this year. To address these challenges, a comprehensive and strategic approach is needed to strengthen the employer-sponsored market > https://owy.mn/3zM2pJ3 #OWHealth #healthcare #health

Hospital at Home (H@H) is revolutionizing healthcare delivery, offering attractive cost savings and immediate relief for health systems. With H@H capabilities in place, health systems can expand into other Care at Home (C@H) modalities such as post-acute care and specialized services. Implementing C@H programs requires operational shifts, but the benefits - improved patient outcomes and reduced costs - are substantial. We explore > https://owy.mn/3xQwNS3 #OWHealth #healthcare #HealthSystems

Delivering the right care, at the right time, in the right place is the goal for healthcare providers. But what is the "right place"? It's a constantly moving target. We've seen care transition from hospitals to ambulatory sites, retail locations, and even the virtual space. Now, delivering care at home (C@H) is emerging as the next frontier. More on the care at home landscape here > https://owy.mn/3XVCwRh #CareAtHome #Innovation #OWHealth

Many health plans face persistent operational challenges, from claims administration to member engagement. Generative AI offers a solution. With its natural language understanding and content creation capabilities, gen AI can help payers develop innovative solutions for long-standing problem areas. In this article, Deepan Vashi of Firstsource outlines where leaders should start > https://owy.mn/3XRqAjp #GenAI #OWHealth #healthcare

Cell and gene therapies (CGTs) have the potential to revolutionize healthcare by treating and curing previously incurable diseases. With a projected compound annual growth rate of 46%, the global market for CGTs is set to reach $37B over the next five years. However, challenges in reimbursement and operating margins hinder commercial viability. To bridge the gap, leaders must focus on pricing strategies and reducing manufacturing costs. How to make cell and gene therapies financially sustainable > https://owy.mn/45NOFcS #OWHealth #CellandGeneTherapy #healthcare

The Affordable Care Act (ACA) has led to the rise of narrow networks in the healthcare industry. HMOs and exclusive provider organization plans now make up 79% of offerings on the ACA Exchange, up from 42% in 2014. This has resulted in a decrease in the availability of less restrictive plans and PPOs. Insurers need to adapt to the dominance of narrow networks and address challenges to ensure growth and sustainability in the evolving marketplace > https://owy.mn/4eENGzK #ACA #Healthcare #OWHealth

Biotech and pharmaceutical companies continue to face workforce challenges. Layoffs in the sector have increased compared to previous years, driven by economic conditions, expiring drug patents, and shifts in strategic priorities. To address these challenges, leadership teams need to be proactive in their strategies. Four key actions to take > https://owy.mn/4bj0WHy #Workforce #OWHealth

When it comes to accessing healthcare, women often encounter a fragmented system. A new wave of innovators determined to disrupt the existing norms and enhance healthcare delivery for women. In this podcast, Minoo Javanmardian, PhD joins Leah Sparks, CEO and Founder of Wildflower Health, and Joanna Strober, CEO and Founder of Midi Health, to explore strategies to integrate women's healthcare more effectively into the broader healthcare ecosystem and bridge the gender health gap. Listen here > https://owy.mn/4eEnfue #healthare #HealthEquity #WomensHealth

In the third installation of our Care at Home series, we dive into the benefits of leveraging vendors versus building internal capabilities, and how to ensure clinician buy-in. At its core, Care at Home includes three key modules: 1. Telehealth tech for seamless communication 2. Remote monitoring for vital signs tracking 3. Command center for resource deployment A variety of platform vendors can support all three modules across the breadth of a C@H operating model, including building the required integrations to the electronic medical record, with varying degrees of sophistication. However, health systems should be aware that vendor solutions are evolving > https://owy.mn/4es3p5a #HealthTech #Innovation #OWHealth

Humira’s loss of exclusivity in 2023 led to a $6 billion revenue drop as 10 biosimilars entered the market. Despite this decline, Humira still held a 97% share. Now, biosimilars like Hyrimoz and Yusimry are gaining ground through innovative pricing and strategic partnerships. Big changes in biosimilars are ahead, offering potential cost savings and better access for patients > https://owy.mn/3VqBJoF #Pharma #Biosimilars #OWHealth